It seemed inevitable that there would either have to be new technology to replace the creaky old vacuum tubs tech of the CTTC Calmare machine or the company would collapse and be overtaken by newer and better devices.
What we now see is that Marineo, having been spurned, snubbed, and tossed aside, has managed to go back to the lab, hire some high-end Milanese designers, engage some new tech manufacturers, and upgrade or tweak the machine. We do not know what adjustments he has made, but there have been enough clinical trials and patients for data to have been collected that could have guided his new device.
What now should be interesting, of course, is whether there will be a patent or marketing rights dispute should Calmare claim they should be marketing the device in the US and elsewhere, or whether they are shut out.
Furthermore, how will the various Calmare clinics react? Are they stuck either by contract or debt to Calmare and must continue with the machines they own, or can they choose to dump the older machines and opt for the ST-5A? Assuming it is not much different in overall operation, the learning curve may not be treacherous or long and, if the price is right, why not buy the latest and greatest. After all, most of us, unless we are antique car collectors, tend to hold their car for 6 years or so, and the Calmare machines are much older. They may also not have replacement parts since, as I recall, the Koreans are no longer making them and they may be scavenging parts from the many unsold units in warehouses (especially since Radio shack and Fry Electronics are gone)
I am assuming that the CEO and the Board Chair must have know this was coming, if not the CEO may now be walking around with a big brown wet spot on the backside of his pants. Shareholders might typically dump out of fear of a drop, but where can the price fall anyway? The only hope now is to convince day traders that Calmare is GameStop in Italian
